The National Community Pharmacists Association and the National Association of Chain Drug Stores has issued a joint statement in which they state that the FTC asked the two pharmacy groups for ways to revise the Medco-Express Scripts deal. The groups, who have been opposed to the acquisition, have responded with suggestions for possible remedies. However, the joint statement also affirms continued criticism of the transaction, and that their preference is for the FTC not to settle, but fight the merger in court.
Featured News
Carey Bolsters Competition Law Team With New Senior Counsel
Mar 15, 2026 by
CPI
TikTok US Sale Could Deliver $10 Billion Windfall to the United States
Mar 15, 2026 by
CPI
States Press Ahead With Live Nation Antitrust Trial After Federal Settlement
Mar 15, 2026 by
CPI
US Pulls Back Draft Regulation Targeting Global AI Chip Shipments
Mar 15, 2026 by
CPI
Selecta and Bondholders Ask US Court to Dismiss Antitrust Lawsuit Over Creditor Pact
Mar 15, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece